Furthermore, we found that calpain-2 is required for FFA treatments-induced cell apoptosis and activation of caspase-12 and caspase-3 in β-cells, which may account for cell apoptosis in hyperlipidemia induced T2DM. The gene discussed is CASP3; the disease is type 2 diabetes mellitus.